SBFM: Sunshine Biopharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 5.30
Enterprise Value ($M) -6.89
Book Value ($M) 25.04
Book Value / Share 12.52
Price / Book 0.21
NCAV ($M) 20.96
NCAV / Share 10.48
Price / NCAV 0.25

Profitability (mra)
Return on Invested Capital (ROIC) -0.17
Return on Assets (ROA) -0.15
Return on Equity (ROE) -0.20

Liquidity (mrq)
Quick Ratio 3.57
Current Ratio 5.74

Balance Sheet (mrq) ($M)
Current Assets 25.98
Assets 30.06
Liabilities 5.02
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Policy Basic n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Armistice Capital, Llc 0.00 -100.00
02-23 13G L1 Capital Global Opportunities Master Fund, Ltd. 5.30
02-21 13G Altium Capital Management LP 9.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-03-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 1,189 8,026 14.81
2025-02-03 26,172 103,134 25.38
2025-01-31 18,690 51,311 36.42
2025-01-30 19,353 41,670 46.44

(click for more detail)

Similar Companies
RZLT – Rezolute, Inc. SABS – SAB Biotherapeutics, Inc.
SAVA – Cassava Sciences, Inc. SCLX – Scilex Holding Company
SGMO – Sangamo Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io